PhD in Biomedical Sciences and Biotechnology

 

Home –  PhD students –  Faculty –  Seminars

 

              1. degli Uberti EC, Bondanelli M, Margutti A, Ambrosio MR, Valentini A, Campo M, Franceschetti P, Zatelli MC, Pansini R, Trasforini G. Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide. Neuroendocrinology. 1996, 64(5):398-404.
              2. Rossi R, Zatelli MC, Franceschetti P, Maestri I, Magri E, Aguiari G, Cavazzini P, degli Uberti EC, del Senno L. Inhibitory effect of dihydrotestosterone on human thyroid cell growth. J Endocrinol. 1996; 151(2):185-94.
              3. Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P, Valentini A, Pansini R, degli Uberti EC. Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism. 1997; 46(1):107-13.
              4. Zatelli MC, Rossi R, del Senno L, degli Uberti EC. Role of Transforming Growth Factor b 1 (TGF b 1) in mediating androgen-induced growth inhibition in human adrenal cortex in vitro. Steroids. 1998;63(5-6):243-5.
              5. Ambrosio MR, Campo M, Zatelli MC, Cella SG, Trasforini G, Margutti A, Rigamonti AE, Muller EE, degli Uberti EC. Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion. Neuroendocrinology. 1998; 68(2):123-8.
              6. Rossi R, Zatelli MC, Valentini A, Cavazzini P, Fallo F, del Senno L, degli Uberti EC. Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells. J Endocrinol. 1998;159(3):373-80.
              7. Zatelli MC, Rossi R, degli Uberti EC.  Androgen influences Transforming Growth Factor b1 (TGFb1) gene expression in human adrenocortical cells. J Clin Endocrinol Metab. 2000; 85(2):847-52.
              8. Bousquet C, Zatelli MC, Melmed S. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest. 2000;106(11):1417-25.
              9. Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD, degli Uberti EC. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line, TT. J Clin Endocrinol Metab. 2001; 86(5):2161-9.
              10. Pasini B, Rossi R, Ambrosio MR, Zatelli MC, Gullo M, Gobbo M, Collini P, Aiello A, Pansini G, Trasforini G, degli Uberti EC. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschprung’s disease. Surgery. 2002; 131(4):373-81.
              11. Zatelli MC, Tagliati F, Taylor JE, Piccin D, Culler MD, degli Uberti EC. Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. Horm Metab Res. 2002; 34(5):229-33.
              12. Zatelli MC, Tagliati F, Piccin D, Taylor JE, Culler MD, Bondanelli M, degli Uberti EC. Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. Biochem Biophys Res Commun. 2002; 297(4):828-34.
              13. Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, degli Uberti EC. Evidence for integrity of the growth hormone/insulin-like growth factor-I axis in patients with severe head trauma during rehabilitation. Metabolism. 2002;51(10):1363-9.
              14. Zatelli MC, Piccin D, Tagliati F, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Culler MD, degli Uberti EC. Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. J Clin Endocrinol Metab. 2003;88(6):2797-802.
              15. Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, degli Uberti EC. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function. Neuroendocrinology. 2003; 77(6):380-7.
              16. Zatelli MC, Piccin D, BondanelliM, TagliatiF, De CarloE, CullerMD, degli Uberti EC. An in vivo Octreoscan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro. Horm Metab Res. 2003; 35(6):349-54.
              17. Zatelli MC, Roti E, degli Uberti EC. Somatostatin and thyroid. J Endocrinol Invest. 2003; 26(8):765-6.
              18. Zatelli MC, degli Uberti EC. Somatostatin receptors: from basic science to clinical approach – Thyroid.    Dig Liver Dis. 2004; 36 Suppl 1:S86-92.
              19. Bondanelli M, Zatelli MC, Ambrosio MR, degli Uberti EC. The vascular complications of acromegaly. J Endocrinol Invest. 2003; 26(8 Suppl): 28-31.
              20. Bondanelli M, De Marinis L, Ambrosio MR, Monesi M, Valle D, Zatelli MC, Fusco A, Bianchi A, Farneti M, degli Uberti EC. Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma. 2004; 21(6):685-96.
              21. Zatelli MC, Piccin D, Bottoni A, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Taylor JE, Culler MD, Cavazzini L, degli Uberti EC. Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro. J Clin Endocrinol Metab. 2004; 89(10):5181-8.
              22. Zatelli MC, degli UbertiEC. Somatostatin signal transduction in thyroid parafollicular C cells. J Endocrinol Invest. 2004. 27(6 Suppl):168-70.
              23. Zatelli MC, Scanarini M, Bondanelli M, Ambrosio MR, degli Uberti EC. Cerebral aneurysm and acromegaly: a case report. J Endocrinol Invest.2004; 27(8):770-3.
              24. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol. 2005; 204(1):280-5.
              25. Zatelli MC, Maffei P, Piccin D, Martini C, Rea F, Rubello D, Margutti A, Culler MD, Sicolo N, degli Uberti EC. Somatostatin analogs in vitro effects in a growth hormone-releasing hormone (GHRH)-secreting bronchial carcinoid. J Clin Endocrinol Metab. 2005; 90(4):2104-9.
              26. Zatelli MC, Piccin D, Tagliati F, Bottoni A, Luchin A, degli Uberti EC. Src homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma. Endocrinology. 2005; 146: 2692-8.
              27. David A, Blotta A, Rossi R, Zatelli MC, Bondanelli M, Roti E, Braverman LE, Busutti L, degli Uberti EC. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. Thyroid. 2005; 15(3):267-73.
              28. Bondanelli M, Ambrosio MR, Zatelli MC, Cavazzini L, Al Jandali Rifa’y L, degli Uberti EC. Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy. World J Gastroenterol. 2005; 11(13):2041-4.
              29. Bondanelli M, Ambrosio MR, Zatelli MC, De Marinis L, degli Uberti EC. Hypopituitarism after traumatic brain injury. Eur J Endocrinol. 2005; 152(5):679-91.
              30. Tagliati F, Bottoni A, Bosetti A, Zatelli MC, degli Uberti EC. Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system. J Pharm Biomed Anal. 2005; 39(3-4):811-4.
              31. Zatelli MC, Luchin A, Piccin D, Tagliati F, Bottoni A, Vignali C, Bondanelli M, degli UbertiEC. Cyclooxigenase-2 Inhibitors Reverse Chemoresistance Phenotype in Medullary Thyroid Carcinoma by a P-gp Mediated Mechanism. J Clin Endocrinol Metab. 2005; 90(10):5754-60.
              32. Bondanelli M, Bonadonna S, Ambrosio MR, Doga M, Gola M, Onofri A, Zatelli MC, Giustina A, degli Uberti EC. Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism. Metabolism. 2005; 54(9):1174-80.
              33. Zatelli MC, Piccin D, Tagliati F, Bottoni A, Ambrosio MR, Margutti A, Scanarini M, BondanelliM, Culler MD, degli Uberti EC. Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro. J Mol Endocrinol. 2005; 35(2):333-41.
              34. degli Uberti EC, Bondanelli M, Ambrosio MR, Zatelli MC. Review of Cortina criteria for the diagnosis of acromegaly. J Endocrinol Invest. 2005; 28 (11 Suppl International):70-2.
              35. Zatelli MC, Piccin D, Tagliati F, Bottoni A, Luchin A, Vignali C, Margutti A, Bondanelli M, Pansini GC, Pelizzo MR, Culler MD, degli Uberti EC. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. J Clin Endocrinol Metab. 2006; 91(6):2218-24.
              36. Tagliati F, Zatelli MC, Bottoni A, Piccin D, Luchin A, Culler MD, degli Uberti  EC. Role of complex Cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro. Endocrinology. 2006; 147(7):3530-8.
              37. Zatelli MC, Piccin D, Ambrosio MR, Bondanelli M, degli Uberti EC. Antiproliferative effects of somatostatin analogs in pituitary adenomas. Pituitary. 2006; 9(1):27-34.
              38. Bondanelli M, Ambrosio MR, Onofri A, Bergonzoni A, Lavezzi S, Zatelli MC, Valle D, Basaglia N, degli Uberti EC. Predictive value of circulating IGF-I levels in ischemic stroke outcome. J Clin Endocrinol Metab. 2006; 91(10):3928-34.
              39. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, degli Uberti EC. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 2007; 210(2): 370-7.
              40. Florio P, Zatelli MC, Reis FM, degli Uberti EC, Petraglia F. Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders? Front Biosci. 2007. 1;12:551-60.
              41. Zatelli MC, Piccin D, Vignali C, Tagliati F, Ambrosio MR, Bondanelli M, Cimino V, Bianchi V, Schmid HA, Scanarini M, Pontecorvi A, De Marinis L, Maira G, degli Uberti EC. Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. Endocr Relat Cancer. 2007; 14(1):91-102.
              42. Zatelli MC, Ambrosio MR, Bondanelli M, degli Uberti EC. Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds. Eur J Endocrinol. 2007; 156 Suppl 1:S29-35. (I.F. 3.892). (Q1). (n. citazioni 6).
              43. Bottoni A, Vignali C, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC. Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. J Cell Physiol. 2007; 212(2):293-7.
              44. Zatelli MC, Torta M, Leon A, Ambrosio MR, Gion M, Tomassetti P, De Braud F, Delle Fave G, Dogliotti L, degli Uberti EC on behalf of the Italian CromaNet Working Group. Chromogranin A as a marker of neuroendocrine neoplasia: an italian multicenter study. Endocr Relat Cancer. 2007; 14(2):473-82.
              45. Bondanelli M, Ambrosio MR, Zatelli MC, degli Uberti EC. Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. J Neurotrauma. 2007; 24(11):1687-9.
              46. Zatelli MC, Luchin A, Tagliati F, Leoni S, Piccin D, Bondanelli M, Rossi R, degli Uberti EC. Cyclooxigenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting P-gp expression. Endocr Relat Cancer. 2007; 14(4):1029-38.
              47. De Carlo E, Pilon C, Zatelli MC, degli Uberti EC, Fallo F. The isolated R171Q aminoacid change in MEN1 gene: polymorphism or mutation? Clin Endocrinol (Oxf). 2008; 69(3):511.
              48. Zatelli MC, Ambrosio MR, Bondanelli M, degli Uberti EC.   In vitro testing of new somatostatin analogs on pituitary tumor cells. Mol Cell Endocrinol. 2008; 286(1-2):187-91.
              49. Rossi R, Roti E, Trasforini G, Pansini G, Cavazzini L, Zatelli MC, Pearce EN, Braverman LE, degli Uberti EC. Differentiated thyroid cancers 11-20 mm in diameter are more aggressive than those ≤ 10 mm.Thyroid. 2008; 18(3):309-15.
              50. Bondanelli M, Zatelli MC, Ambrosio MR, degli Uberti EC. Systemic illness. Pituitary.2008; 11(2):187-207.
              51. Fusco A, Zatelli MC, Bianchi A, Cimino V, Tilaro L, Veltri F, Angelini F, Lauriola L, Vellone V, Doglietto F, Ambrosio MR, Maira G, Giustina A, degli Uberti EC, Pontecorvi A, De Marinis L.Prognostic significance of the Ki-67 labelling index in GH-secreting pituitary adenomas. J Clin Endocrinol Metab 2008; 93(7):2746-50.
              52. Zatelli MC, degli Uberti EC. MicroRNAs and possible role in pituitary adenoma. Reprod Med. 2008; 26(6):453-60.
              53. Bondanelli M, Ambrosio MR, Zatelli MC, Basaglia N, degli Uberti EC. Prevalence of hypopituitarism in patients with cerebrovascular diseases. J Endocrinol Invest. 2008; 31(9 Suppl):16-20.
              54. Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. Eur J Endocrinol. 2009; 161(3): 467-73.
              55. Zatelli MC, Minoia M, Molè D, Cason V, Tagliati F, Margutti A, Bondanelli M, Ambrosio MR, degli Uberti E. Growth hormone excess promotes breast cancer chemoresistance. J Clin Endocrinol Metab. 2009; 94(10): 3931-8.
              56. Zatelli MC, Molè D, Tagliati F, Minoia M, Ambrosio MR, degli Uberti E. Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kB. Cell Oncol. 2009; 31(6): 457-65.
              57. Verrua E, Ronchi CL, Ferrante E, Ferrari DI, Bergamaschi S, Ferrero S, Zatelli MC, Branca V, Spada A, Beck-Peccoz P, Lania AG. Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma. Pituitary. 2010; 13(3):289-92.
              58. Zatelli MC, Minoia M, Filieri C, Tagliati F, Buratto M, Ambrosio MR, Lapparelli M, Scanarini M, degli Uberti EC. Effect of everolimus on cell viability in nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 2010; 95(2):968-76.
              59. Zatelli MC, Gentilin E, Daffara F, Tagliati F, Reimondo G, Carandina G, Ambrosio MR, Terzolo M, degli Uberti EC. Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. Endocrinology. 2010; 151(6):2453-61.
              60. Romei C, Mariotti S, Fugazzola L, Taccaliti A, Pacini F, Opocher G, Mian C, Castellano M, Ceccherini I, Degli Uberti E, Cremonini N, Seregni E, Orlandi F, Ferolla P, Puxeddu E, Giorgino F, Colao A, Loli P, Bondi F, Cosci B, Bottici V, Cappai A, Pinna G, Persani L, Uberta V, Boscaro M, Casatagna M, Cappelli C, Zatelli MC, Faggiano A, Francia G, Brandi ML, Falchetti A, Pinchera A, Elisei R. Multiple Endocrine Neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol. 2010, 163(2):301-8.
              61. Zatelli MC, Minoia M, Martini C, Tagliati F, Ambrosio MR, Schiavon M, Buratto M, Calabrese F, Gentilin E, Cavallesco G, Berdonini L, Rea F, degli Uberti EC. Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.Endocr Relat Cancer. 2010; 17(3):719-29.
              62. Bondanelli M, Ambrosio MR, Carli A, Bergonzoni A, Bertocchi A, Zatelli MC, Ceruti S, Valle D, Basaglia N, degli Uberti EC. Predictors of pituitary dysfunction in patients surviving ischemic stroke.   J Clin Endocrinol Metab. 2010; 95(10):4660-8.
              63. Tagliati F, Gentilin E, Buratto M, Molè D, Degli Uberti EC, Zatelli MC. Magmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuli. Endocrinology. 2010; 151(10):4635-42.
              64. Molatore S, Marinoni I, Lee M, Pulz E, Ambrosio MR, Uberti EC, Zatelli MC, Pellegata NS. A novel germline CDKN1B mutation causing multiple endocrine tumors:clinical, genetic and functional characterization. Hum Mutat. 2010; 31(11):E1825-35.
              65. Zatelli MC, Tagliati F, Amodio V, Buratto M, Pelizzo M, Pansini G, Bondanelli M, Ambrosio MR, degli Uberti E. Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma. Anal Cell Pathol (Amst). 2010; 33(5):207-16.
              66. Martínez-Fuentes AJ, Molina M, Vázquez-Martínez R, Gahete MD, Jiménez-Reina L, Moreno-Fernández J, Benito-López P, QuinteroA, de la Riva A, Diéguez C, Soto A, Leal-Cerro A, Resmini E, Webb SM, Zatelli MC, degli Uberti EC, Malagón MM, Luque RM, Castaño JP. Expression of functional KiSS-1 and KiSS-1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. Eur J Endocrinol. 2011; 164(3):355-62.
              67. De Bellis A, Pane E, Bellastella G, Sinisi AA, Colella C, Giordano R, Giavoli C, Lania A, Ambrosio MR, Di Somma C, Zatelli MC, Arvat E, Colao A, Bizzarro A, Bellastella A, Italian Autoimmune Hypophysitis Network Study. Detection of anti-pituitary and anti-hypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism. Clin Endocrinol (Oxf). 2011; 75(3):361-6.
              68. Molé D, Gagliano T, Gentilin E, Tagliati F, Pasquali C, Ambrosio MR, Pansini G, degli Uberti EC, Zatelli MC. Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors. Endocr Relat Cancer. 2011; 18(4):439-50.
              69. Lee M, Theodoropoulou M, Graw J, Roncaroli F, Zatelli MC, Pellegata NS. Levels of p27 sensitize to dual PI3K/mTOR inhibition. Mol Cancer Ther. 2011; 10(8):1450-9.
              70. Piccini V, Rapizzi E, Bacca A, Di Trapani G, Pulli R, Giachè V, Zampetti B, Lucci-Cordisco E, Canu L, Corsini E, Faggiano A, Deiana L, Carrara D, Tantardini V, Mariotti S, Ambrosio MR, Zatelli MC, Parenti G, Colao A, Pratesi C, Bernini G, Ercolino T, Mannelli M. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer. 2012; 19(2):149-55.
              71. Molè D, Gentilin E, Gagliano T, Tagliati F, Bondanelli M, Pelizzo MR, Rossi M, Filieri C, Pansini G, degli Uberti EC, Zatelli MC. Protein Kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro. Endocrinology. 2012; 153(5):2088-98.
              72. Minoia M, Gentilin E, Molè D, Rossi M, Filieri C, Tagliati F, Baroni A, Ambrosio MR, Degli Uberti E, Zatelli MC. Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. J Clin Endocrinol Metab. 2012; 97(6):E907-16.
              73. Dalle Carbonare L, Frigo A, Francia G, Davì MV, Donatelli L, Stranieri C, Brazzarola P, Zatelli MC, Menestrina F, Valenti MT. Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer. J Clin Endocrinol Metab. 2012; 97(7):E1249-56.
              74. Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, degli Uberti EC, Zatelli MC. Role of ultrasonographic/clinical profile, cytology and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study. J Clin Endocrinol Metab. 2012; 97(7):2354-61.
              75. Caselli E, Zatelli MC, Rizzo R, Benedetti S, Martorelli D, Trasforini G, Cassai E, degli Uberti EC, Di Luca.D, Dolcetti R. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog. 2012; 8(10):e1002951.
              76. Gagliano T, Filieri C, Minoia M, Buratto M, Tagliati F, Ambrosio MR, Lapparelli M, Zoli M, Frank G, degli Uberti E, Zatelli MC. Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. Pituitary. 2013; 16(1):91-100.
              77. Zatelli MC, Torre ML, Rossi R, Ragonese M, Trimarchi F, degli Uberti E, Cannavò S. Should AIP gene screening be recommended in family members of FIPA patients with R16H variant? Pituitary. 2013; 16(2):238-44.
              78. Marotta V, Guerra A, Zatelli MC, Di Stasi V, Faggiano A, Colao A, Vitale M. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto’s thyroiditis lymphocytic infiltration is present. Clin Endocrinol (Oxf). 2013; 79(5):733-8.
              79. Gentilin E, Tagliati F, Filieri C, Molè D, Minoia M, Ambrosio MR, degli Uberti EC, Zatelli MC. miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating Protein Kinase C delta. Endocrinology. 2013; 154(5):1690-700.
              80. Sala E, Ferrante E, Verrua E, Malchiodi E, Mantovani G, Filopanti M, Ferrero S, Pietrabissa A, Vanoli A, La Rosa S, Zatelli MC, Beck-Peccoz P, Verga U. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype. Eur J Gastroenterol Hepatol. 2013; 25(7):858-62.
              81. Gagliano T, Bellio M, Gentilin E, Molè D, Tagliati F, Schiavon M, Cavallesco NG, Andriolo LG, Rea F, degli Uberti EC, Zatelli MC. mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids. Endocr Relat Cancer. 2013; 20(4):463-75.
              82. Gentilin E, Tagliati F, Terzolo M, Zoli M, Lapparelli M, Minoia M, Ambrosio MR, degli Uberti EC, Zatelli MC. Mitotane reduces human and mouse ACTH-secreting pituitary cells viability and function. J Endocrinol. 2013; 218(3):275-85.
              83. Franceschetti P, Bondanelli M, Caruso G, Ambrosio MR, Lorusso V, Zatelli MC, Massari L, degli Uberti EC. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy. Bone. 2013; 56(2):426-31.
              84. Tagliati F, Gagliano T, Gentilin E, Minoia M, Molè D, degli Uberti EC, Zatelli MC. Magmas overexpression inhibits staurosporine induced apoptosis in rat pituitary adenoma cell lines. PLoS One.2013; 17;8(9):e75194.
              85. Reimondo G, Bondanelli M, Ambrosio MR, Grimaldi F, Zaggia B, Zatelli MC, Allasino B, Laino F, Aroasio E, Termine A, Conton P, Paoletta A, Demenis E, Uberti ED, Terzolo M. Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment. Endocrine. 2014; 45(1):122-7.
              86. Ferone D, Pivonello C, Vitale G, Zatelli MC, Colao A, Pivonello R. Molecular basis of pharmacological therapy in Cushing's disease. Endocrine. 2014; 46(2):181-98.
              87. Gentilin E, Molè D, Gagliano T, Minoia M, Ambrosio MR, degli Uberti EC, Zatelli MC. Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines. Reprod Toxicol. 2014; 31;45C:71-76.
              88. Zatelli MC, Tagliati F, Di Ruvo M, Castermans E, Cavazzini L, Daly AF, Ambrosio MR, Beckers A, degli Uberti EC. Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression. Fam Cancer. 2014; 13(2):273-80.
              89. Zatelli MC, Gagliano T, Pela M, Bianco S,Bertolasi V, Tagliati F, Guerrini R, degli Uberti E, Salvadori S, Trapella C. The N-carbamimidoyl 4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances Staurosporine cytotoxic effects likely inhibiting the protective action of Magmas towards cell apoptosis. J Med Chem. 2014; 57(11):4606-14.
              90. Carcoforo P, Portinari M, Feggi L, Panareo S, De Troia A, Zatelli MC, Trasforini G, degli Uberti E, Forini E, Feo CV. Radioguided Selective Compartment Neck Dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow up. Surgery. 2014; 156(1):147-157.
              91. Zatelli MC, Ambrosio MR, Bondanelli M, degli Uberti E. Pituitary side effects  of old and new drugs. J Endocrinol Invest. 2014; 37(10): 917-23.
              92. Gagliano T, Gentilin E, Benfini K, Di Pasquale C, Tassinari M, Falletta S, Feo C, Tagliati F, Uberti ED, Zatelli MC. Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells. Endocrine. 2014; 47(3):943-51.
              93. Panzuto F, Rinzivillo M, Fazio N, de Braud F, Luppi G, Zatelli MC, Lugli F, Tomassetti P, Riccardi F, Nuzzo C, Brizzi MP, Faggiano A, Zaniboni A, Nobili E, Pastorelli D, Cascinu S, Merlano M, Chiara S, Antonuzzo L, Funaioli C, Spada F, Pusceddu S, Fontana A, Ambrosio MR, Cassano A, Campana D, Cartenì G, Appetecchia  M, Berruti A, Colao A, Falconi M, Delle Fave G. Real-world study of everolimus in advanced progressive neuroendocrine tumors. Oncologist. 2014; 19(9):966-74.
              94. Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg JH, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy PA, Ferrante E, Strebkova N, Mazerkina N, Zatelli MC, Lodish M, Horvath A, de Alexandre RB, Manning AD, Levy I, Keil MF, Sierra Mde L, Palmeira L, Coppieters W, Georges M, Naves LA, Jamar M, Bours V, Wu TJ, Choong CS, Bertherat J, Chanson P, Kamenický P, Farrell WE, Barlier A, Quezado M, Bjelobaba I, Stojilkovic SS, Wess J, Costanzi S, Liu P, Lupski JR, Beckers A, Stratakis CA. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med. 2014; 371(25):2363-74.
              95. Marcucci G, Cianferotti L, Beck-Peccoz P, Capezzone M, Cetani F, Colao A, Davì MV, Degli Uberti E, Del Prato S, Elisei R, Faggiano A, Ferone D, Foresta C, Fugazzola L, Ghigo E, Giacchetti G, Giorgino F, Lenzi A, Malandrino P, Mannelli M, Marcocci C, Masi L, Pacini F, Opocher G, Radicioni A, Tonacchera M, Vigneri R, Zatelli MC, Brandi ML. Rare diseases in clinical endocrinology: a taxonomic classification system. J Endocrinol Invest. 2015; 38(2):193-259.
              96. Werner RA, Bluemel C, Lassmann M, Kudlich T, Higuchi T, Lopci E, Allen-Auerbach M, Colletti PM, Rubello D, Zatelli MC, Herrmann K. SPECT- and PET-Based Patient-Tailored Treatment in Neuroendocrine Tumors: A Comprehensive Multidisciplinary Team Approach. Clin Nucl Med. 2015; 40(5):e271-7.
              97. Kandathil A, Wong KK, Wale DJ, Zatelli MC, Maffione AM, Gross MD, Rubello D. Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature. Endocrine. 2015; 49(1):6-26.
              98. Rossi M, Buratto M, Tagliati F, Rossi R, Lupo S, Trasforini G, Lanza G, Franceschetti P, Bruni S, Degli Uberti E, Zatelli MC. Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer. Thyroid. 2015; 25(2):221-8.
              99. Sambugaro S, Di Ruvo M, Ambrosio MR, Pellegata NS, Bellio M, Guerra A, Buratto M, Foschini MP, Tagliati F, degli Uberti E, Zatelli MC Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region. Endocrine. 2015; 49(1):58-64.
              100. Beckers A, Lodish M, Giampaolo T, Rostomyan L, Lee M, Faucz FR, Yuan B, Choong C, Caberg JH, Verrua E, Naves LA, Cheetham T, Young J, Lysy P, Petrossians P, Cotterill A, Shah N, Metzger D, Castermans E, Ambrosio MR, Villa C, Strebkova N, Mazerkina N, Gaillard S, Barcelos Barra G, Casulari LA, Neggers S, Salvatori R, Jaffrain-Rea ML, Zacharin M, Lecumberri Santamaria B, Zacharieva S, Lim EM, Mantovani G, Zatelli MC, Collins MT, Bonneville JF, Quezado M, Chittiboina P, Oldfield E, Bours V, Liu P, de Herder WW, Pellegata NS, Lupski JR, Daly AF, Stratakis CA. X-linked acrogigantism (X-LAG) syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer. 2015; 22(3):353-67.
              101. Molè D, Gentilin E, Ibañez-Costa A, Gagliano T, Gahete MD, Tagliati F, Rossi R, Pelizzo MR, Pansini G, Luque RM, Castaño JP, Degli Uberti E, Zatelli MC. The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. Endocrine. 2015; 50(2):442-52.
              102. Battocchio M, Zatelli MC, Chiarelli S, Trento M, Ambrosio MR, Pasquali C, De Carlo E, Dassie F, Mioni R, Rebellato A, Fallo F, Degli Uberti E, Martini C, Vettor R, Maffei P. Ovarian tumors secreting insulin. Endocrine. 2015; 49(3):611-9.
              103. Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, Lecumberri B, Trivellin G, Salvatori R, Moraitis AG, Holdaway I, Kranenburg-van Klaveren DJ, Zatelli MC, Palacios N, Nozieres C, Zacharin M, Ebeling T, Ojaniemi M, Rozhinskaya L, Verrua E, Jaffrain-Rea ML, Filipponi S, Gusakova D, Pronin V, Bertherat J, Belaya Z, Ilovayskaya I, Sahnoun-Fathallah M, Sievers C, Stalla GK,  Castermans E, Caberg JH, Sorkina E, Auriemma RS, Mittal S, Kareva M, Lysy PA, Emy P, De Menis E, Choong CS, Mantovani G, Bours V, De Herder W, Brue T, Barlier A, Neggers SJ, Zacharieva S, Chanson P, Shah NS, Stratakis CA, Naves LA, Beckers A.  Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer. 2015 Oct;22(5):745-57.  doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17. PubMed PMID: 26187128.
              104. Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A, Pivonello R; ABC Study Group. Conventional  and Nuclear Medicine Imaging in ectopic Cushing’s Syndrome: a systematic review. J Clin Endocrinol Metab. 2015; 100(9):3231-44.
              105. Gagliano T, Gentilin E, Tagliati F, Benfini K, Di Pasquale C, Feo C, Falletta S, Riva E, Degli Uberti E, Zatelli MC. Inhibition of Epithelial Growth Factor Receptor can play an important role in reducing cell growth and survival in adrenocortical tumors Biochem Pharmacol. 2015; 98(4):639-48 doi: 10.1016/j.bcp.2015.10.012.
              106. Gentilin E, Di Pasquale C, Gagliano T, Tagliati F, Benfini K, Ambrosio MR, Bondanelli M, degli Uberti EC, Zatelli MC Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells. Mol Cell Endocrinol. 2016; 419:252-8. doi: 10.1016/j.mce.2015.10.025.
              107. Feo CV, Portinari M, Maestroni U, Del Rio P, Severi S, Viani L, Pravisani R, Soliani G, Zatelli MC, Ambrosio MR, Tong J, Terrosu G, Bresadola V. Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients. Surg Endosc. 2015 Nov 5. [Epub ahead of print] PubMed PMID: 26541739.
              108. Rizzo R, Zatelli MC, Rotola A, Cassai E, Degli Uberti E, Di Luca D, Caselli E. Increase in Peripheral CD3(-)CD56(bright)CD16(-) Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection. Adv Exp Med Biol. 2016;897:113-20.
              109. Zatelli MC, Fanciulli G, Malandrino P, Ramundo V, Faggiano A, Colao A; NIKE Group. Predictive factors of response to mTOR inhibitors in neuroendocrine tumours. Endocr Relat Cancer. 2016;23(3):R173-83.
              110. Daly AF, Yuan B, Fina F, Caberg JH, Trivellin G, Rostomyan L, de Herder WW, Naves LA, Metzger D, Cuny T, Rabl W, Shah N, Jaffrain-Rea ML, Zatelli MC, Faucz FR, Castermans E, Nanni-Metellus I, Lodish M, Muhammad A, Palmeira L, Potorac I, Mantovani G, Neggers SJ, Klein M, Barlier A, Liu P, Ouafik L, Bours V, Lupski JR, Stratakis CA, Beckers A. Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects. Endocr Relat Cancer. 2016 Apr;23(4):221-33.
              111. Borsari S, Pardi E, Pellegata NS, Lee M, Saponaro F, Torregrossa L, Basolo F, Paltrinieri E, Zatelli MC, Materazzi G, Miccoli P, Marcocci C, Cetani F. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas. Endocrine. 2017 Feb;55(2):386-397. doi: 10.1007/s12020-016-0941-6. Epub 2016 Apr 2. PubMed PMID: 27038812.
              112. Martini C, Zanchetta E, Di Ruvo, Nalesso A, Battocchio M, Gentilin E, degli Uberti E, Vettor R, Zatelli MC. Cushing in a leaf: endocrine disruption from a natural remedy. J Clin Endocrinol Metab. 2016.     Aug;101(8):3054-60. PubMed PMID: 27218272. doi: 10.1210/jc.2016-1490.
              113. Gentilin E, Minoia M, Bondanelli M, Tagliati F, degli Uberti EC, Zatelli MC. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines. Endocrine. 2016 Sep 1. [Epub ahead of print] PubMed PMID: 27585662.
              114. Rossi M, Lupo S, Rossi R, Franceschetti P, Trasforini G, Bruni S, Tagliati F, Buratto M, Lanza G, Damiani L, Degli Uberti E, Zatelli MC. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses. Endocrine. 2016 Sep 13. [Epub ahead of print] PubMed PMID: 27623969.
              115. Falletta S, Partelli S, Rubini C, Nann D, Doria A, Marinoni I, Polenta V, Di Pasquale C, Degli Uberti EC, Perren A, Falconi M, Zatelli MC. mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors. . Endocr Relat Cancer. 2016 Nov;23(11):883-891. Epub 2016 Oct 3. PubMed PMID: 27697900.
              116. Gentilin E, Degli Uberti E, Zatelli MC. Strategies to use microRNAs as therapeutic targets. Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):629-639. doi: 10.1016/j.beem.2016.10.002. Review. PubMed PMID: 27923456.
              117. Caselli E, D'Accolti M, Soffritti I, Zatelli MC, Rossi R, degli Uberti E, Di Luca D. HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis. Virol J. 2017 Jan 11;14(1):3. doi: 10.1186/s12985-016-0672-6. PubMed PMID: 28081700.
              118. Davi' MV, Cosaro E, Piacentini S, Reimondo G, Albiger N, Arnaldi G, Faggiano A, Mantovani G, Fazio N, Piovesan A, Arvat E, Grimaldi F, Canu L, Mannelli M, Ambrogio AG, Pecori Giraldi F, Martini C, Lania A, Albertelli M, Ferone D, Zatelli MC, Campana D, Colao A, Scaroni C, Terzolo M, De Marinis L, Cingarlini S, Micciolo R, Francia G. Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study. Eur J Endocrinol. 2017 Apr;176(4):451-459. doi: 10.1530/EJE-16-0809. PubMed PMID: 28183788.
              119. Zatelli MC, Grossrubatscher EM, Guadagno E, Sciammarella C, Faggiano A, Colao  AA. Circulating tumor cells and miRNA as prognostic markers in neuroendocrine neoplasms. Endocr Relat Cancer. 2017 Apr 7. pii: ERC-17-0091. doi: 10.1530/ERC-17-0091. [Epub ahead of print] PubMed PMID: 28389504.
                          Azioni sul documento